Curcumin protects against iron induced neurotoxicity in primary cortical neurons by attenuating necroptosis

Neuroscience Letters

Volumn 536, Issue 1, 2013, Pages 41-46

  Dai, Min chao ^a   Zhong, Zhi hong ^a   Sun, Yu hao ^a   Sun, Qing fang ^a   Wang, Yong ting ^a,b   Yang, Guo yuan ^a,b   Bian, Liu guan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Curcumin; Necroptosis; Primary cortical neuron; Receptor interacting protein 1

Indexed keywords

BRAIN PROTEIN; CURCUMIN; FERROUS CHLORIDE; LACTATE DEHYDROGENASE; NECROSTATIN 1; NUCLEAR PROTEIN; RECEPTOR INTERACTING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CELL; CELL COUNT; CELL LYSATE; CELL VIABILITY; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IRON OVERLOAD; MOUSE; NECROPTOSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CEREBRAL CORTEX; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FERROUS COMPOUNDS; IRON OVERLOAD; MICE; MICE, INBRED C57BL; NECROSIS; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 84873741905     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.01.007     Document Type: Article

References (38)

1. Baum L., Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. Journal of Alzheimers Disease 2004, 6(4):367-377. discussion 443-9.
2. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with n-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(16):7162-7166.
3. Carmody R.J., Cotter T.G. Signalling apoptosis: a radical approach. Redox Report 2001, 6(2):77-90.
4. Chen C.-W., Chen T.-Y., Tsai K.-L., Lin C.-L., Yokoyama K.K., Lee W.-S., Chiueh C.C., Hsu C. Inhibition of autophagy as a therapeutic strategy of iron-induced brain injury after hemorrhage. Autophagy 2012, 8(10):78-79.
5. Chen W.-W., Yu H., Fan H.-B., Zhang C.-C., Zhang M., Zhang C., Cheng Y., Kong J., Liu C.-F., Geng D., Xu X. RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons. Journal of Neurochemistry 2012, 120(1):70-77.
6. Crichton R.R., Wilmet S., Legssyer R., Ward R.J. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. Journal of Inorganic Biochemistry 2002, 91(1):9-18.
7. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., Cuny G.D., Mitchison T.J., Moskowitz M.A., Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chemical Biology 2005, 1(2):112-119.
8. Du X.X., Xu H.M., Jiang H., Song N., Wang J., Xie J.X. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. Neuroscience Bulletin 2012, 28(3):253-258.
9. Festjens N., Vanden Berghe T., Cornelis S., Vandenabeele P. RIP1 a kinase on the crossroads of a cell's decision to live or die. Cell Death and Differentiation 2007, 14(3):400-410.
10. Galluzzi L., Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008, 135(7):1161-1163.
11. Giommarelli C., Zuco V., Favini E., Pisano C., Dal Piaz F., De Tommasi N., Zunino F. The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition. Cellular and Molecular Life Sciences 2010, 67(6):995-1004.
12. Gupta S.C., Prasad S., Kim J.H., Patchva S., Webb L.J., Priyadarsini I.K., Aggarwal B.B. Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports 2011, 28(12):1937.
13. Han J., Shi S., Min L., Wu T., Xia W., Ying W. NAD+ treatment induces delayed autophagy in Neuro2a cells partially by increasing oxidative stress. Neurochemical Research 2011, 36(12):2270-2277.
14. Hashimoto Y., Jiang H., Niikura T., Ito Y., Hagiwara A., Umezawa K., Abe Y., Murayama Y., Nishimoto I. Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. Journal of Neuroscience 2000, 20(22):8401-8409.
15. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135(7):1311-1323.
16. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 2000, 1(6):489-495.
17. Hsu C.H., Cheng A.L. Clinical studies with curcumin. Advances in Experimental Medicine and Biology 2007, 595:471-480.
18. Huang F.P., Xi G., Keep R.F., Hua Y., Nemoianu A., Hoff J.T. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. Journal of Neurosurgery 2002, 96(2):287-293.
19. Jaisin Y., Thampithak A., Meesarapee B., Ratanachamnong P., Suksamrarn A., Phivthong-Ngam L., Phumala-Morales N., Chongthammakun S., Govitrapong P., Sanvarinda Y. Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis. Neuroscience Letters 2011, 489(3):192-196.
20. Jiang D., Li X., Williams R., Patel S., Men L., Wang Y., Zhou F. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry 2009, 48(33):7939-7947.
21. Kaech S., Banker G. Culturing hippocampal neurons. Nature Protocols 2006, 1(5):2406-2415.
22. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.Q., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R.A., Bush A.I., Andersen J.K. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003, 37(6):899-909.
23. Li Y., Yang X., Ma C., Qiao J., Zhang C. Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neuroscience Letters 2008, 447(2-3):120-123.
24. Liu W., Fan Z., Han Y., Lu S., Zhang D., Bai X., Xu W., Li J., Wang H. Curcumin attenuates peroxynitrite-induced neurotoxicity in spiral ganglion neurons. Neurotoxicology 2011, 32(1):150-157.
25. Luo Y., Hattori A., Munoz J., Qin Z.H., Roth G.S. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Molecular Pharmacology 1999, 56(2):254-264.
26. Mack C., Sickmann A., Lembo D., Brune W. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(8):3094-3099.
27. Miwa C.P., de Lima M.N., Scalco F., Vedana G., Mattos R., Fernandez L.L., Hilbig A., Schroder N., Vianna M.R. Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats. Neurotoxicity Research 2011, 19(4):527-535.
28. Pelizzoni I., Macco R., Morini M.F., Zacchetti D., Grohovaz F., Codazzi F. Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 2011, 10(1):172-183.
29. Sangchot P., Sharma S., Chetsawang B., Porter J., Govitrapong P., Ebadi M. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture. Developmental Neuroscience 2002, 24(2-3):143-153.
30. Schotte P., Declercq W., Van Huffel S., Vandenabeele P., Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Letters 1999, 442(1):117-121.
31. Sun Y., Dai M., Wang Y., Wang W., Sun Q., Yang G.Y., Bian L. Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice. Journal of Neurotrauma 2011, 28(12):2513-2521.
32. Tiwari V., Chopra K. Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacology (Berl) 2012.
33. Tsai Y.M., Chien C.F., Lin L.C., Tsai T.H. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. International Journal of Pharmaceutics 2011, 416(1):331-338.
34. Xu Q., Kanthasamy A.G., Reddy M.B. Phytic acid protects against 6-hydroxydopamine-induced dopaminergic neuron apoptosis in normal and iron excess conditions in a cell culture model. Parkinson's Disease 2011, 2011:431068.
35. Xu X., Chua K.W., Chua C.C., Liu C.F., Hamdy R.C., Chua B.H. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Research 2010, 1355:189-194.
36. Yanagisawa D., Shirai N., Amatsubo T., Taguchi H., Hirao K., Urushitani M., Morikawa S., Inubushi T., Kato M., Kato F., Morino K., Kimura H., Nakano I., Yoshida C., Okada T., Sano M., Wada Y., K.-n.Wada, Yamamoto A., Tooyama I. Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease. Biomaterials 2010, 31(14):4179-4185.
37. Zhang Z., Wei T., Hou J., Li G., Yu S., Xin W. Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. European Journal of Pharmacology 2003, 467(1-3):41-47.
38. Zhu X., Tao L., Tejima-Mandeville E., Qiu J., Park J., Garber K., Ericsson M., Lo E.H., Whalen M.J. Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice. Stroke 2012, 43(2):524-531.